Mutant Prevention Concentrations of Fluoroquinolones for Clinical Isolates of Streptococcus pneumoniae

The mutant prevention concentration (MPC) represents a threshold above which the selective proliferation of resistant mutants is expected to occur only rarely. A provisional MPC (MPC(pr)) was defined and measured for five fluoroquinolones with clinical isolates of Streptococcus pneumoniae. Based on...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Blondeau, Joseph M., Zhao, Xilin, Hansen, Glen, Drlica, Karl
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 2001
Aiheet:	Mechanisms of Resistance
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90309/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11158737/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.2.433-438.2001
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!